Comparison of Syringes With Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates in Brolucizumab, Aflibercept and Bevacizumab

PURPOSE: In a benchwork particle counting analytical evaluation, the number and type of particles in intravitreal injection formulations of three different agents against vascular endothelial growth factor were investigated. METHODS: Commercially available ready-to-use aflibercept and brolucizumab g...

Descripción completa

Detalles Bibliográficos
Autores principales: Schargus, Marc, Kopp, Katharina Tatjana, Helbig, Constanze, Frings, Andreas, Winter, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375009/
https://www.ncbi.nlm.nih.gov/pubmed/34406342
http://dx.doi.org/10.1167/tvst.10.9.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375009/
https://www.ncbi.nlm.nih.gov/pubmed/34406342
http://dx.doi.org/10.1167/tvst.10.9.21

Ejemplares similares